{"nctId":"NCT00490815","briefTitle":"Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema","startDateStruct":{"date":"2007-08"},"conditions":["Diabetic Macular Edema"],"count":37,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Fluocinolone Acetonide"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Fluocinolone Acetonide"]}],"interventions":[{"name":"Fluocinolone Acetonide","otherNames":[]},{"name":"Fluocinolone Acetonide","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\>= 18 years with diabetic macular edema\n* Diagnosis of diabetes mellitus types 1 or 2\n* Best corrected visual acuity of â‰¥ 19 letters\n* Retinal thickness \\> 250 microns by OCT\n* Investigator is comfortable deferring macular laser treatment for 6 weeks\n\nExclusion Criteria:\n\n* Glaucoma, ocular hypertension, IOP \\>21 mmHg or concurrent therapy at screening with IOP lowering agents\n* Retinal or choroidal neovascularization due to ocular conditions other than diabetic retinopathy\n* Prior intravitreal, subtenon, or periocular steroid therapy within the last 3 months\n* Prior intravitreal or subtenon anti-VEGF therapy within the last 2 months\n* Any ocular surgery within the last 3 months\n* Retinal laser treatment within the last 3 months\n* History of uncontrolled IOP elevation with steroid use that did not respond to topical therapy\n* Any lens opacity which impairs visualization of the posterior pole","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Levels of Fluocinolone Acetonide in Plasma and Aqueous Humor","description":"This was a combined assessment of the levels of fluocinolone acetonide in the plasma and aqueous humor. The average values of the data collected is entered in Outcome Data.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4905","spread":"1.87058"},{"groupId":"OG001","value":"0.7140","spread":"0.78096"}]}]}]},{"type":"SECONDARY","title":"Retinal Thickness","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"343.8","spread":"142.92"},{"groupId":"OG001","value":"324.2","spread":"136.86"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":19,"n":20},"commonTop":["Cataract","Conjunctival haemorrhage","Myodesopsia","Intraocular pressure increased","Cataract"]}}}